Louise Carter, MBBS PhD

The Division of Cancer Sciences, The University of Manchester and Department of Medical Oncology, The Christie NHS Foundation Trust, United Kingdom

Poster(s):

• (P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS